Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8801702 Systems and methods for treatment of BPH

Patent 8801702 was granted and assigned to NxThera on August, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

NxThera

Current Assignee

NxThera

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8801702

Date of Patent

August 12, 2014

Patent Application Number

13764645

Date Filed

February 11, 2013

Patent Citations Received

‌

US Patent 12121228 Expandable tissue engagement apparatus and method

‌

US Patent 12102383 Tissue resection device with motors and control circuitry

‌

US Patent 12108964 Minimally invasive tissue treatment device

‌

US Patent 11672520 Expandable tissue engagement apparatus and method

‌

US Patent 11759258 Controlled ablation with laser energy

‌

US Patent 11779430 Vapor based ablation system for treating uterine bleeding

‌

US Patent 11786287 Systems and methods for treating the prostate

...

Patent Primary Examiner

‌

Linda Dvorak

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8801702 Systems and methods for treatment of BPH

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API